GSK plc announced the purchase of 345,000 ordinary shares on March 26, 2026, at an average price of 2,053.34 pence as part of its buyback program, accumulating a total of 15,201,521 shares purchased since February 17, 2026. Post-transaction, GSK holds 255,092,615 treasury shares, with a total of 4,061,083,663 shares in issue.